Somatic gene therapy in the cardiovascular system

Area of Science:

• Cardiovascular Research
• Gene Therapy
• Regenerative Medicine

Background:

• Vascular endothelial growth factor (VEGF) is crucial for blood vessel development and function.
• Therapeutic angiogenesis aims to stimulate new blood vessel growth to treat ischemic diseases.
• Gene transfer offers a method to deliver therapeutic genes like VEGF.

Purpose of the Study:

• To review gene therapy approaches using plasmid DNA encoding VEGF165 for vascular modulation.
• To focus on strategies for augmenting collateral circulation and promoting re-endothelialization.
• To discuss the significance of VEGF and identify future research challenges.

Main Methods:

• Review of intra-arterial and intramuscular/intramyocardial gene transfer of VEGF165.
• Analysis of studies focusing on therapeutic angiogenesis and restenosis prevention.
• Examination of the developmental and postnatal roles of VEGF.

Main Results:

• Plasmid DNA encoding VEGF165 is a key tool for modulating endothelial cells.
• Gene transfer strategies have been investigated in clinical settings for arterial insufficiency and post-angioplasty restenosis.
• VEGF plays a vital role in both developmental and postnatal vascularization.

Conclusions:

• Gene therapy with VEGF165 holds potential for treating vascular diseases.
• Further research is required to address limitations and challenges in clinical application.
• Optimizing gene delivery and understanding VEGF's complex roles are critical for future success.